Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MOKRZYCKI, M. H.
Right arrow Articles by FEINGOLD, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MOKRZYCKI, M. H.
Right arrow Articles by FEINGOLD, R.
J Am Soc Nephrol 11:2122-2127, 2000
© 2000 American Society of Nephrology

Tunneled-Cuffed Catheter Associated Infections in Hemodialysis Patients Who Are Seropositive for the Human Immunodeficiency Virus

MICHELE H. MOKRZYCKI*,{dagger},{ddagger}, BERND SCHRÖPPEL*,{dagger}, GERO VON GERSDORFF*,{dagger}, HEATHER RUSH*,{ddagger}, MIROSLAW P. ZDUNEK*,{ddagger} and ROBERT FEINGOLD*,{ddagger}

* Division of Nephrology, Albert Einstein College of Medicine, Bronx, New York.
{dagger} Departments of Medicine, Jacobi Medical Center, Bronx, New York.
{ddagger} Montefiore Medical Center, Bronx, New York.

Correspondence to Dr. Michele H. Mokrzycki, Associate Professor of Clinical Medicine, 3332 Rochambeau Avenue, Centennial 423, Montefiore Medical Center, Bronx, NY 10467. Phone: 718-920-5442; Fax: 718-652-8384; E-mail: mokrzm{at}aol.com

Abstract. Infection rates in tunneled-cuffed catheters (TCC) are reported to be higher in immunocompromised patients. The purpose of this study was to evaluate TCC-associated infection rates in patients with HIV infection (HIV+). Data were collected in 40 HIV + patients and 41 controls (C), and in 118 TCC (HIV+, 58; C, 60) for 28,146 catheter days (HIV+, 16,227; C, 11,919). There were no significant differences in the TCC bacteremia rates (HIV+, 2.23 versus C, 2.53 per 1000 TCC days, P = NS) or in the TCC exit site infection rates (HIV+, 2.20 versus C, 2.24 per 1000 TCC days, P = NS) between the groups. The number of TCC removed due to infection was also similar, (HIV+ versus C: 17 versus 15%, P = NS). In the HIV+ group, the association of hepatitis B surface antigenemia with TCC exit site infection was dependent on the history of injection drug use. Black race was a significant risk factor for higher TCC exit site infection rates, whereas prophylactic antibiotic use and high CD4 count were significantly associated with lower TCC exit site infection rates. None of the factors significantly predicted bacteremia rate in either group (HIV+ or C). In comparison to controls, HIV+ patients had a fivefold increased risk of having a Gramnegative organism (P = 0.02) and a sevenfold increased risk of a fungal isolate (P = 0.08), although the latter finding was not statistically significant. HIV infection is not a significant risk factor for TCC-associated infection but is associated with a higher prevalence of Gram-negative and fungal species.




This article has been cited by other articles:


Home page
 VASC ENDOVASCULAR SURGHome page
A. F. Schild, E. A. Perez, E. Gillaspie, A. R. Patel, K. Noicely, and N. Baltodano
Use of the Vectra Polyetherurethaneurea Graft for Dialysis Access in HIV-Positive Patients With End-Stage Renal Disease
Vascular and Endovascular Surgery, January 1, 2008; 41(6): 506 - 508.
[Abstract] [PDF]

Home page
 CJASNHome page
M. Allon
Current Management of Vascular Access
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 786 - 800.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
D. Mitchell, Z. Krishnasami, and M. Allon
Catheter-related bacteraemia in haemodialysis patients with HIV infection
Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3185 - 3188.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
A. Falk
Use of the brachiocephalic vein for placement of tunneled hemodialysis catheters.
Am. J. Roentgenol., September 1, 2006; 187(3): 773 - 777.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
L. Golestaneh, J. Laut, S. Rosenberg, M. Zhang, and M. H. Mokrzycki
Favourable outcomes in episodes of Pseudomonas bacteraemia when associated with tunnelled cuffed catheters (TCCs) in chronic haemodialysis patients
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1328 - 1333.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
J. K. Inrig, S. D. Reed, L. A. Szczech, J. J. Engemann, J. Y. Friedman, G. R. Corey, K. A. Schulman, L. B. Reller, and V. G. Fowler Jr.
Relationship between Clinical Outcomes and Vascular Access Type among Hemodialysis Patients with Staphylococcus aureus Bacteremia
Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 518 - 524.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. H. Mokrzycki, M. Zhang, H. Cohen, L. Golestaneh, J. M. Laut, and S. O. Rosenberg
Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality
Nephrol. Dial. Transplant., April 1, 2006; 21(4): 1024 - 1031.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. H. Mokrzycki and A. Singhal
Cost-effectiveness of three strategies of managing tunnelled, cuffed haemodialysis catheters in clinically mild or asymptomatic bacteraemias
Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2196 - 2203.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673